Characterization and pharmacokinetics of coenzyme Q 10 nanoparticles prepared by a rapid expansion of supercritical solution process

Xiangdong Meng,Yuangang Zu,Xiuhua Zhao,Qingyong Li,ShouGang Jiang,Mei Sang
DOI: https://doi.org/10.1691/ph.2012.1086
2012-01-01
Pharmazie
Abstract:Coenzyme Q(10) (CoQ(10)) has been found to be effective in cardiovascular diseases and neurodegenerative diseases. However, the extremely poor solubility of CoQ(10) in water is hampering its bioavailability as a therapeutic agent. To overcome solubility problem, we micronized the CoQ(10) powder to the nanometer level by the supercritical solution (RESS) process, which does not employ any toxic organic solvent. The obtained CoQ(10) nanoparticles were 147.9 +/- 27.3 nm in diameter and their physicochemical properties were characterized by scanning electron microscopy (SEM), dynamic light scattering (DLS), liquid chromatography mass spectrometry (LC-MS), X-ray diffractometry (XRD) and differential scanning calorimetry (DSC) analyzes. Moreover, the pharmacokinetics of the CoQ(10) nanoparticles, in comparison with the unprocessed CoQ(10) powder, were investigated in rats. From the results of physicochemical and pharmacokinetic studies, the CoQ(10) nanoparticles had high solubility in water and possessed less crystalline structure, which can enhance the bioavailability of CoQ(10), and provide a water-soluble solid dosage form of CoQ(10).
What problem does this paper attempt to address?